Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited, a leader in healthcare imaging, announced a record half-year net profit of $51.7 million, marking a 42.7% increase from the previous period. Significant growth in North American revenues and key contract wins, including agreements with Trinity Health and others, contributed to this success. The company remains debt-free and declared an interim dividend of 25 cents per share. The continued success is attributed to strong margins, new contract implementations, and a robust pipeline, showcasing confidence in Pro Medicus’ technology as clients transition to cloud solutions.
More about Pro Medicus Limited
Pro Medicus Limited, founded in 1983, is a leading healthcare informatics company providing medical imaging software and services to hospitals, imaging centers, and healthcare groups worldwide. The acquisition of Visage Imaging in 2009 transformed the company into a global provider of cutting-edge medical imaging solutions.
YTD Price Performance: 12.77%
Average Trading Volume: 343
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $18.78B
See more insights into PME stock on TipRanks’ Stock Analysis page.
